Duloxetine versus placebo in the prevention of recurrence of major depressive disorder.
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Major depressive disorder
- Focus Registrational; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 Dec 2008 Results data presented in a media release from Lilly.
- 11 May 2008 Status changed from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History